Short seller Norris: Covid vaccines are no ‘silver bullet’

Loading player...
Barry Norris, founder and chief executive of Argonaut Capital, tells us why he thinks the market reaction to coronavirus vaccine breakthroughs has been too positive, how short-selling does more good for society than ESG investing, and why he is considering expanding the universe of his European long-only funds to include global stocks.
18 Nov 2020 English United Kingdom Business · Investing

Other recent episodes

Ex-Aberdeen leader on why wealth firms can't ignore digital assets

As the world of traditional finance and digital assets converge, Duncan Moir, traded a long career at Aberdeen for a role in the digital frontier. In this episode, Moir explains why wealth managers who fail to integrate digital assets into portfolios risk being fundamentally left behind in the race for…
14 May 27 min

FCA on red tape cuts: This is just the start

Nick Hulme, head of advisers, wealth and pensions at the FCA, discusses why the regulator is not an 'amorphous blob', and what its growth initiatives will look like for firms in real time.
6 May 26 min

Gresham House: Brooks set to be 'very attractive' takeover candidate

Ken Wotton, Managing Director of Public Equity at Gresham House, and lead manager of Strategic Equity Capital discussed the significant undervaluation of UK wealth management firms, which feature prominently in his fund alongside the expectation for growth in the UK M&A market.
24 Apr 26 min